Affiliation:
1. Universidad Nacional Autónoma de México (UNAM). Facultad de Medicina. Departamento de Microbiología y Parasitología. Laboratorio de Inmunomodulación y Agentes Patógenos. Ciudad de México. México
2. niversidad Nacional Autónoma de México (UNAM). Facultad de Medicina. Departamento de Microbiología y Parasitología. Unidad de Micología. Ciudad de México. México
Abstract
The first compounds with specific antifungal activity were identified in the middle of the last century as a product of the secondary metabolism of bacteria of the order Actinomycetales, and their clinical use significantly diminished the morbidity and mortality associated with severe fungal infections. Many of such biosynthetic compounds are characterized by a chemical polygenic structure, with a variable number of carbon-carbon double bonds. Currently, besides polygenic antimycotics, there are other antifungal agents, such as the azole compounds, that have less toxicity in patients; however,
cases of therapeutic failure with such compounds have been documented, therefore, the use of polygenics is still the best alternative in such cases. This review presents data about the properties and applications of antifungal-polygenic compounds using amphotericin B as a model.
Key words: Amphotericin B; antifungal polyenes; ergosterol
Publisher
Universidad Nacional Autonoma de Mexico
Reference36 articles.
1. 1. Galagan JE, Henn MR, Ma LJ, Cuomo CA, Birren B. Genomics of the fungal kingdom: Insights into eukaryotic biology. Genome Res. 2005;15(12):1620-31. manual of mental disorders: DSM-5. 5th ed. Washington, D.C.: American Psychiatric Association; 2013.
2. 2. Editorial Nat Microbiol. Stop neglecting fungi. Nat Microbiol. 2017;2(17120):1.
3. 3. Bongomin F, Gago S, Oladele R, Denning D. Global and multi-national prevalence of fungal diseases —estimate precision. J Fungi (Basel). 2017;3(4):57
4. 4. Galanis E, MacDougall L. Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999-2007. Emerg Infect Dis. 2010;16(2):251-7
5. 5. Miguel P, Allevato AJ, Negroni PR, Galimberti PR. Antifúngicos ayer, hoy y mañana. Act Terap Dermatol. 2007; 30:8-19.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献